LTUS   $0.0105  -12.50% Market Closed

Lotus Pharmaceuticals Inc
Total Cash 158.91K
totalCashPerShare 0.006
EBITDA 10.31M
Total Debt 6.18M
quickRatio 0.434
currentRatio 0.532
Total Revenue 71.39M
debtToEquity 6.217
Revenue/Share 2.602
ROA 0.04557
ROE 0.01824
grossProfits
freeCashflow -5.29M
operatingCashflow 18.37M
earningsGrowth -0.82
revenueGrowth 0.04
grossMargins 0.35645
ebitdaMargins 0.14435
operatingMargins 0.066599995
profitMargins 0.024319999
enterpriseValue 6.13M
forwardPE
floatShares
sharesOutstanding 2.69B
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.0
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 3.577
Price To Book help_outline 0.00
earningsQuarterlyGrowth -0.81
netIncomeToCommon 1.72M
trailingEps -0.03%
forwardEps
enterpriseToEbitda 0.59
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Oct. 17, 2024, 3:59 a.m.